Charles River Laboratories INTERNATIONAL, Inc. (CRL) intrinsic value & 10-year financials
Charles River Laboratories INTERNATIONAL, Inc. (CRL) has a Graham intrinsic value of $4.23 per share. At $300.15 on Oct 17, 2026, the stock trades 6996% above that value. Over the last 10 fiscal years revenue grew 10.2% a year to $4.0B, with an average return on invested capital of 7.9%.
- Graham intrinsic value
- $4.23
- Share price (Oct 17, 2026)
- $300.15
- Price vs Graham value
- 6996% above
- Market cap
- $14.9B
- Revenue (FY2025)
- $4.0B
- Revenue growth (10-yr CAGR)
- 10.2%
- ROIC (10-yr avg)
- 7.9%
- Free cash flow (FY2025)
- $518.5M
CRL 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $4.0B | -$144.3M | -$2.91 | $518.5M | 0.6% | 0.5% |
| FY2024 | $4.0B | $22.2M | $0.20 | $501.6M | 5.6% | 2.0% |
| FY2023 | $4.1B | $474.6M | $9.22 | $365.4M | 14.9% | 8.9% |
| FY2022 | $4.0B | $486.2M | $9.48 | $294.9M | 16.4% | 9.9% |
| FY2021 | $3.5B | $391.0M | $7.60 | $532.0M | 16.7% | 11.1% |
| FY2020 | $2.9B | $364.3M | $7.20 | $380.0M | 14.8% | 10.0% |
| FY2019 | $2.6B | $252.0M | $5.07 | $340.4M | 13.4% | 9.8% |
| FY2018 | $2.3B | $226.4M | $4.62 | $301.1M | 14.6% | 11.2% |
| FY2017 | $1.9B | $123.4M | $2.54 | $235.6M | 15.5% | 7.3% |
| FY2016 | $1.7B | $154.8M | $3.23 | $261.6M | 14.1% | 8.6% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Charles River Laboratories is a consistent compounder, expanding top-line revenue at 10.2% annually over the past decade.
Charles River Laboratories has historically struggled to out-earn its cost of capital, averaging just 7.9% ROIC.
Over the decade, Charles River Laboratories shows that the company has leveraged its balance sheet to sustain operations.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Charles River Laboratories is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $4.23 per share.